Discovery & Development
Incyte's drug discovery efforts were founded in 2002 by a team of world-class scientists striving to create innovative medicines for patients. The rigorous pursuit of scientific excellence remains at the core of our company today.
Our discovery approach integrates target selection, portfolio "fit," compound quality, and pharmacodynamic optimization. This approach ensures we not only develop molecules with characteristics optimized for their intended use but also build a portfolio that is strategically coherent and synergy-rich.